Objective: In view of our previous finding that the intravenous infusion of
2-ketoisocaproate (KIC) improved survival in septic rats, we endeavored to
determine whether the enteral infusion of KIC improves survival in endotox
ic rats, and, if so, the mechanism of this effect,
Subjects: Eighty-five rats were given 15 mg/kg of Escherichia coli lipopoly
saccharide(026:B6).
Interventions: KIC, sodium pyruvate (PYR), or sodium bicarbonate (HCO,) was
infused continuously intragastrically at 18.75 mmol/kg/day.
Measurements and Main Results: KIC administration increased circulating con
centrations of KIC and ketone bodies, Survival rates were: KIC 17/32; PYR 2
/22; and HCO3 8/31. The significant improvement in survival with KIC, in co
ntrast with HCO3 (p<.04) or PYR (p <.002), points to an effect specific to
KIC rather than to ketoacids generally, and argues against an antioxidant m
echanism to explain improved survival with enteral administration, To deter
mine whether altered nitric oxide production was responsible, plasma nitrit
e plus nitrate concentrations were measured sequentially in rats given a lo
wer dose of lipopolysaccharide plus continuous intragastric KIC, PYR, or HC
O3, All rats exhibited pronounced increases in plasma nitrite plus nitrate
concentrations, peaking at 8 hrs, but both KIC and PYR caused greater incre
ases than HCO3. Thus, differences in nitric oxide production cannot account
for the different effects of PYR and KIC on survival, However, KIC infusio
n for 8 hrs substantially increased ketone bodies in blood and liver, in co
mparison with the infusion of HCO3 or PYR,
Conclusion: Continuous enteral infusion of KIC improves survival in endotox
emia, probably by its conversion to ketone bodies, which serve as an altern
ative energy substrate.